In addition, SORL1 expression was higher in tumors exhibiting high ERBB3 and ERBB2 expression (Fig. 1B; breast cancer patient data from the METABRIC study on the cBioportal database [25–27]). This evidence concerns the gene ERBB2 and breast cancer.